We are only able to display limited information for this firm. We display more complete information for all of the following firms:
At Trilegal Harsh Maggon secialises in public and private M&A and private equity transactions including takeover offers, schemes of arrangement and delisting offers involving healthcare and life sciences including hospital and pharma companies. Yogesh Singh, who heads the corporate practice group, is a seasoned advisor to investors and financial institutions on M&A, private equity, corporate finance and restructuring transactions on both inbound and outbound transactions. Also key partners, Kosturi Ghosh (in Bengaluru) handles inbound and outbound acquisitions and joint ventures together with regulatory guidance while Kirti Balasubramanian has over a decade of IP commercialisation and enforcement experience.
Legal 500 Editorial commentary
Key clients
- Manipal Global Health Services (MGHS) and MHEPL (Manipal Group)
- Glenmark Life Sciences Limited
Abbreviated data is displayed for this firm.
Work highlights
- Advised the Manipal Group (MGHS and MHEPL) in: (a) sale of 41% stake in MHEPL by MGHS and Cypress Holdings to Temasek (b) acquisition by MGHS of 21.52% stake held by TPG VI in MHEPL (c) acquisition by MGHS of 8.45% stake held by National Investment and Infrastructure Fund - II (NIIF) in MHEPL (d) sale of 11% stake in MHEPL by MGHS to TPG VIII.
- Represented Glenmark Life Sciences Limited a listed pharmaceutical manufacturer of APIs, in the proposed sale of 75% equity shares of GLS by Glenmark Pharmaceuticals Limited (“GPL”) to Nirma Limited.
Abbreviated data is displayed for this firm.